Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

Taking finasteride before surgery reduces blood loss in prostate procedures.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Medical treatments for benign prostatic hyperplasia mainly relieve symptoms, while surgery is more effective but not always suitable for elderly patients.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The normal human prostate does not significantly affect blood DHT levels.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Obesity is linked to more severe lower urinary tract symptoms.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.